Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @PharmaVOICE
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PharmaVOICE
-
This month’s Upfront features news from
@MylanNews,@Astellas,@Allergan, as well as#PV100s Jay Carter and Wendy White, and#HBA’s announcement of the 2020 Woman of the Year, Honorable Mentor and STAR honorees. https://www.pharmavoice.com/digital-edition/february-2020/#8 …pic.twitter.com/oDuhUvTRt2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In today’s
#WoW podcast, Lindsay McNair, M.D., Chief Medical Officer@WCGClinical discusses her nontraditional career path from surgeon to clinical bioethics expert and how skills she acquired on the way were a perfect match for her role at WCGClinical. https://www.pharmavoice.com/wow-podcasts/wow-lindsay-mcnair/ …pic.twitter.com/bUnN8Noy79
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
What's urgent for 2020? A report from the
@SyneosHealth Insights Hub identifies 15 trends impacting drug development and commercialization. Download report to gain access to all 15 trends and a blueprint for navigating the dynamic healthcare environment. https://bit.ly/2YoKtxz pic.twitter.com/1cp8WblY1P
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
An expert in bioethics as well as a physician, Dr. Lindsay McNair brings deep expertise and empathy to her role as chief medical officer
@WCGClinical as she looks to transform the clinical trial paradigm. Listen in tomorrow on the#WoW podcast with@tgrom. https://www.pharmavoice.com/wow-podcasts/ pic.twitter.com/zIUDUBajcV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Due to the acceleration of innovation in oncology therapies in recent years, the cancer death rate is down 25% since its peak in 1991, making nearly 1 in 20 Americans a cancer survivor.
#WorldCancerDay
Here’s an update on today's oncology market: https://www.pharmavoice.com/digital-edition/february-2020/#40 …pic.twitter.com/PwTA8chPxh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Great initiative by
@OgilvyHealth to spread the word about Cancer Day and how working together we can make a difference in the lives of those affected by#cancer.#WorldCancerDay
#everydaymattershttps://twitter.com/OgilvyHealth/status/1224709453112659973 …
1:23Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Editor-in-Chief
@tgrom gives an overview of the industry topics covered in this month's February 2020 issue, including the practice of drug repurposing and#raredisease drug development. https://www.pharmavoice.com/digital-edition/february-2020/#5 …pic.twitter.com/UvrmyWEOFe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Virtual health has several applications in pharma, from clinical trials to R&D, patient care to patient monitoring. Experts from
@SignantHealth and@IQVIA_global provide insight on the role of virtual health. https://www.pharmavoice.com/digital-edition/january-2020/#26 …pic.twitter.com/Qvc50ydxEJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The DIA 2020 Global Annual Meeting is more than just ameeting: it’s where brilliant minds come together to create solutions and focuson the future of health. Get Advance Rates through February 13. http://ow.ly/4fec50y328u pic.twitter.com/jApQQwCjwl
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
No matter the audience, storytelling remains a meaningful way to create relationships, inform & educate consumers, & build on a brand. Experts from
@avantHC,@Intouchsol &@CarlingComm discuss tips. https://www.pharmavoice.com/digital-edition/january-2020/#22 …pic.twitter.com/cIquhqd3PN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
.
@SignantHealth Rauha Tulkki-Wilke believes in digital health & its ability to provide better access to healthcare –just as mobile banking has enabled new ways for commerce. She discusses the pro & cons of digital tools like eCOA in today's#WoW podcast. https://www.pharmavoice.com/wow-podcasts/wow-rauha-tulkki-wilke …pic.twitter.com/xFCbhoomef
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
When developing messaging for a high-science therapy, Amy Graham, Client Engagement Officer
@OgilvyHealth says the first step is to recognize the role clinical and regulatory strategy has on messaging. To read more tips: https://www.pharmavoice.com/digital-edition/january-2020/#20 …pic.twitter.com/SkdJjUaXtc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As SVP of Product Management
@SignantHealth, Rauha Tulkki-Wilke leads a global virtual clinical team in creating eCOA solutions that provide many benefits for sites and patients. Listen in tomorrow to hear more during the weekly#WoW podcast with@tgrom. https://www.pharmavoice.com/wow-podcasts/ pic.twitter.com/fsJSY4DkDV
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The growth of high-science brands has changed the life sciences landscape, and with it the strategies companies need to market their products.
@AvantHC,@ogilvy,@W2OGroup contribute their insights. https://www.pharmavoice.com/digital-edition/january-2020/#18 …pic.twitter.com/ukCseLmkGm
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, small pharma companies are overwhelmingly driving innovation, accounting for 63% of all new prescription drug approvals over the past five years. Our experts outline what is in store for these burgeoning partnerships. https://www.pharmavoice.com/digital-edition/january-2020/#14 …pic.twitter.com/FQg1iIHxUC
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
How is the current regulatory environmentdirectly impacting the daily activities of medical affairs and scientificcommunications professionals?
#MASC20 Early Bird Rates expire January 30! http://ow.ly/Vbxk50xW6BM pic.twitter.com/anwKSLRymZ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
In this month's Last Word, Fabrice Chouraqui, former president of Novartis Pharmaceuticals US, discusses his vision for creating an organization that is fueled by innovation. https://www.pharmavoice.com/digital-edition/january-2020/#50 …pic.twitter.com/ZmwCcdba7T
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn about the molecular biology of the endocannabinoid system and new targets for a wide range of diseases at
@Lifesciences_GE’s iCBD3. Check out the agenda here: http://bit.ly/2kwjWYy pic.twitter.com/sMi0SVoe0o
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Susan Dorfman has driven success at
@CMI_Compas for 10 years, mentoring her team to excel, while working side by side with all. Her intriguing career story starts as a young immigrant with a passion for healthcare. Listen now on today’s#WoW podcast! https://www.pharmavoice.com/wow-podcasts/wow-susan-dorfman/ …pic.twitter.com/OVHhK0Mbay
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Find out how research institutions and agri-biotech are using gene editing technologies to advance their research at
#PlantGenomicsGE. Check out the agenda: http://bit.ly/2nAshTN pic.twitter.com/FM9nTBdUxE
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.